A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

NCT04571489 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Gimatecan
DRUG: tegafur, gimeracil and oteracil potassium
DRUG: gemcitabine

Sponsor

Lee's Pharmaceutical Limited